IN2015DN03065A - - Google Patents

Info

Publication number
IN2015DN03065A
IN2015DN03065A IN3065DEN2015A IN2015DN03065A IN 2015DN03065 A IN2015DN03065 A IN 2015DN03065A IN 3065DEN2015 A IN3065DEN2015 A IN 3065DEN2015A IN 2015DN03065 A IN2015DN03065 A IN 2015DN03065A
Authority
IN
India
Application number
Inventor
Rakesh Kumar
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of IN2015DN03065A publication Critical patent/IN2015DN03065A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
IN3065DEN2015 2012-10-22 2015-04-13 IN2015DN03065A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261716790P 2012-10-22 2012-10-22
PCT/US2013/065829 WO2014066204A1 (en) 2012-10-22 2013-10-21 Combination

Publications (1)

Publication Number Publication Date
IN2015DN03065A true IN2015DN03065A (en) 2015-10-02

Family

ID=50545139

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3065DEN2015 IN2015DN03065A (en) 2012-10-22 2015-04-13

Country Status (12)

Country Link
US (1) US20150272950A1 (en)
EP (1) EP2908816A4 (en)
JP (1) JP2015534987A (en)
KR (1) KR20150073989A (en)
CN (1) CN104736154A (en)
AU (1) AU2013334945A1 (en)
BR (1) BR112015008681A2 (en)
CA (1) CA2888976A1 (en)
IN (1) IN2015DN03065A (en)
MX (1) MX2015005114A (en)
RU (1) RU2015119226A (en)
WO (1) WO2014066204A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2485593T3 (en) * 2009-10-08 2015-06-30 Novartis Ag Combination
WO2011150044A1 (en) * 2010-05-26 2011-12-01 Glaxosmithkline Llc Combination
US20130004481A1 (en) * 2011-01-12 2013-01-03 Boehringer Ingelheim International Gmbh Anticancer therapy
CN103476413B (en) * 2011-01-26 2016-03-16 葛兰素史密斯克莱知识产权有限公司 Combination

Also Published As

Publication number Publication date
EP2908816A4 (en) 2016-06-15
MX2015005114A (en) 2015-07-17
US20150272950A1 (en) 2015-10-01
RU2015119226A (en) 2016-12-10
AU2013334945A1 (en) 2015-04-23
KR20150073989A (en) 2015-07-01
EP2908816A1 (en) 2015-08-26
JP2015534987A (en) 2015-12-07
BR112015008681A2 (en) 2017-07-04
WO2014066204A1 (en) 2014-05-01
CA2888976A1 (en) 2014-05-01
CN104736154A (en) 2015-06-24

Similar Documents

Publication Publication Date Title
BR112014019107A2 (en)
BR112014019099A2 (en)
BR112014017614A2 (en)
BR112014018528A2 (en)
BR112014017592A2 (en)
AR092201A1 (en)
BR112014017607A2 (en)
BR112014019044A2 (en)
BR112013027865A2 (en)
BR112014019330A2 (en)
BR112014017609A2 (en)
BR112014017673A2 (en)
BR112014017588A2 (en)
BR112014013184A8 (en)
BR112014017618A2 (en)
BR112014017630A2 (en)
BR112014017631A2 (en)
BR112014019948A2 (en)
BR112014017667A2 (en)
BR112014017600A2 (en)
BR112014017671A2 (en)
BR112014017596A2 (en)
BR112014018601A2 (en)
BR112014017591A2 (en)
BR112014017589A2 (en)